Scott B Campbell
Overview
Explore the profile of Scott B Campbell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
106
Citations
1042
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cossart A, Isbel N, Campbell S, McWhinney B, Staatz C
Ther Drug Monit
. 2025 Jan;
47(1):161-168.
PMID: 39792549
Background: Therapeutic monitoring is routinely performed to ensure tacrolimus whole-blood concentrations fall within a predefined target. Despite this, patients still experience inefficacy and toxicity that could be related to variability...
2.
De Souza L, Jegatheesan D, Chang-Wai K, Johnson D, Campbell S, Viecelli A, et al.
Intern Med J
. 2024 Dec;
55(2):277-283.
PMID: 39698788
Background: The numbers of Māori and Pasifika peoples with kidney failure living in Australia are rising. However, data describing outcomes of those proceeding to transplantation are limited. This study describes...
3.
Cossart A, Isbel N, Campbell S, McWhinney B, Staatz C
Eur J Drug Metab Pharmacokinet
. 2024 Aug;
49(6):751-761.
PMID: 39210243
Background: The pharmacokinetics of immunosuppressant drugs may change with advancing age, potentially affecting patient outcomes. Objective: To characterise the effects of age on the pharmacokinetic and exposure parameters of tacrolimus,...
4.
Sartain F, Viecelli A, Veitch M, Franklin M, Dymock B, Wells J, et al.
Transpl Int
. 2024 Feb;
37:12019.
PMID: 38323070
Solid organ transplant recipients are at an increased risk of developing skin cancers due to chronic immunosuppression, particularly with calcineurin inhibitors. Tacrolimus is the most prescribed calcineurin inhibitor in this...
5.
King C, Cossart A, Isbel N, Campbell S, Staatz C
Transplant Rev (Orlando)
. 2023 Dec;
38(1):100815.
PMID: 38071930
Purpose: Tremor, headache and insomnia have been linked to the immunosuppressant, tacrolimus. The aim of this systematic review was to determine if there is a correlation between tacrolimus exposure and...
6.
Chan S, Wood D, Hawley C, Campbell K, Campbell S, Cao C, et al.
Clin Transplant
. 2023 Oct;
38(1):e15175.
PMID: 37902121
No abstract available.
7.
Chan S, Hawley C, Pascoe E, Cao C, Campbell K, Campbell S, et al.
Pilot Feasibility Stud
. 2023 Jan;
9(1):11.
PMID: 36647175
Background: Modulating the microbiota in the large intestine of kidney transplant recipients through prebiotic supplementation may prevent infectious complications from occurring. To date, there have been no interventional trials which...
8.
Aljishi M, Isbel N, Jegatheesan D, Johnson D, Cho Y, Campbell S, et al.
Transpl Immunol
. 2022 Dec;
76:101756.
PMID: 36460263
Aim: Angiotensin II type 1 receptor antibody (AT1R Ab) is a non-Human Leucocyte Antigen (HLA) antibody that is maybe associated with early severe kidney transplant rejection and worse graft outcomes....
9.
Cossart A, Staatz C, Isbel N, Campbell S, Cottrell W
Drugs Aging
. 2022 Sep;
39(11):887-898.
PMID: 36175739
Background: Today, older adult patients routinely undergo kidney transplantation. To support graft survival, patients must take immunosuppressant medicines for the rest of their lives. The post-transplant medication regimen is complex,...
10.
Liu C, Campbell S, Li J, Bannerman D, Pascual-Gil S, Kieda J, et al.
Adv Healthc Mater
. 2022 Sep;
11(23):e2201346.
PMID: 36165232
Bioelastomers are extensively used in biomedical applications due to their desirable mechanical strength, tunable properties, and chemical versatility; however, three-dimensional (3D) printing bioelastomers into microscale structures has proven elusive. Herein,...